APA
GMAB icon

American Portfolios Advisors’s Genmab GMAB Stock Holding History

American Portfolios Advisors’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$107K Buy
3,335
+345
+12% +$12.1K ﹤0.01% 1323
2022
Q2 		$97.1K Sell
2,990
-80
-3% -$2.59K ﹤0.01% 1414
2022
Q1 		$111K Sell
3,070
-62
-2% -$2.13K ﹤0.01% 1448
2021
Q4 		$124K Buy
3,132
+668
+27% +$27.9K ﹤0.01% 1405
2021
Q3 		$108K Buy
2,464
+706
+40% +$31.7K ﹤0.01% 1420
2021
Q2 		$71.8K Buy
1,758
+24
+1% +$926 ﹤0.01% 1548
2021
Q1 		$56.9K Buy
1,734
+67
+4% +$2.52K ﹤0.01% 1559
2020
Q4 		$67.8K Sell
1,667
-40
-2% -$1.5K ﹤0.01% 1311
2020
Q3 		$62.5K Buy
1,707
+711
+71% +$25.7K ﹤0.01% 1244
2020
Q2 		$33.8K Sell
996
-55
-5% -$1.5K ﹤0.01% 1433
2020
Q1 		$22.3K Sell
1,051
-1
-0.1% -$22 ﹤0.01% 1492
2019
Q4 		$23.5K Hold
1,052
– – ﹤0.01% 1661
2019
Q3 		$21.3K Buy
+1,052
New +$20.7K ﹤0.01% 1633

Other funds holding GMAB

AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $199B AUM 37.98% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

American Portfolios Advisors's GMAB Position: Q3 2022 in Review

American Portfolios Advisors increased its Genmab (GMAB) stake by 12% in Q3 2022, buying an estimated $12.1K and bringing the position to 3,335 shares worth $107K. The position accounts for ﹤0.01% of the portfolio, ranked #1323.

American Portfolios Advisors first reported a position in GMAB in Q3 2019 and has held it in 13 quarters since. The position peaked at $124K in Q4 2021. 194 funds tracked by Wall St. Rank hold GMAB as of Q3 2022.

  • American Portfolios Advisors held 3,335 shares of Genmab worth $107K as of Q3 2022.
  • American Portfolios Advisors bought 345 Genmab shares in Q3 2022, an estimated $12.1K.
  • Genmab made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #1323 holding.
  • American Portfolios Advisors first reported a position in Genmab in Q3 2019 and has held it in 13 quarters since.
  • American Portfolios Advisors's Genmab position peaked at $124K in Q4 2021.
  • 194 funds tracked by Wall St. Rank held Genmab as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.